28th Jul 2005 10:59
AstraZeneca PLC28 July 2005 ASTRAZENECA PLC The Board of AstraZeneca PLC announces the appointment of David R Brennan asChief Executive with effect from 1 January 2006 upon the retirement at that timeof Sir Tom McKillop. David Brennan is an Executive Director of AstraZeneca PLC and Executive VicePresident, North America, responsible for the Company's business in the US andCanada. Louis Schweitzer, Chairman of AstraZeneca PLC, said: "The Board's appointment ofDavid Brennan is the outcome of a rigorous selection process from a very stronglist of candidates. David has over 30 years' experience in the pharmaceuticalindustry and has played an important part in the development of AstraZeneca.With his fine leadership qualities and a strong and talented management team,the Board is confident that the company will continue to prosper". 28 July 2005 Media Enquiries: Edel McCaffrey, Tel: +44 (0) 207 304 5034 Steve Brown, Tel: +44 (0) 207 304 5033 Investor Enquiries: Mina Blair, Tel: +44 (0) 207 304 5084 Jonathan Hunt, Tel: +44 (0) 207 304 5087 Ed Seage, Tel: +1 302 886 4065 Jorgen Winroth, Tel + 1 212 579 0506 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca